This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1821 |
4. Check minimum number of eventsNone |
1821 |
5. Include endpointsNone |
1821 |
6. Filter based on genotype QC (FinnGen only) |
1821 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Brain meningioma
based on the number of shared cases.
Similar with more cases:
- Brain meningioma, excluding all cancers (controls excluding all cancers)
- Any event in cancer register
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1821 | 1370 | 451 |
| Unadjusted period prevalence (%) | 0.40 | 0.47 | 0.20 |
| Median age at first event (years) | 58.94 | 57.80 | 62.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1658
- Matched controls
- 16582
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
26.6
323.0
826
596
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
356.0
323.0
595
26
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
+∞
323.0
905
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
1155.3
323.0
1126
30
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
395.7
323.0
927
53
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
339.3
310.0
305
11
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
+∞
268.2
250
*
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
169.5
261.6
270
19
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
537.9
239.8
233
5
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
72.7
204.0
232
37
N03AX14
ATC
levetiracetam; systemic
23.4
193.7
285
146
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
12.2
186.2
360
368
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.2
157.9
591
1582
H02AB02
ATC
dexamethasone; systemic
6.1
157.2
494
1073
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
546.4
153.3
150
*
AA1AD
NOMESCO Finland
CT of head and brain
4.1
141.0
732
2657
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
13.9
135.9
243
202
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
19.7
117.7
182
103
N03AF02
ATC
oxcarbazepine; oral
13.5
116.9
211
177
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
298.3
110.4
111
*
ZXC95
NOMESCO Finland
Use of surgical navigator
24.5
107.2
154
69
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
169.8
106.6
111
7
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
+∞
103.2
98
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
350.9
100.2
100
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.7
99.7
315
651
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
16.7
94.0
154
101
D32.03
ICD-10 Finland
Benign meningioma in ventricles
467.2
90.1
89
*
D32.05
ICD-10 Finland
Cerebral meninges
109.4
85.9
93
9
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
43.5
85.4
106
26
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
296.0
83.4
84
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
14.7
82.9
143
106
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
82.7
662
3034
9537/0-C70.0
ICD-O-3
Transitional meningioma of cerebral meninges
+∞
82.0
78
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
12.7
79.4
146
125
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
+∞
78.8
75
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
167.9
76.8
80
5
2152
FHL
Extraction, big brain
167.9
76.8
80
5
N03AB02
ATC
phenytoin; systemic
19.6
72.9
112
61
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
+∞
71.4
68
*
H53.4
ICD-10 Finland
Visual field defects
11.0
67.7
133
130
XCK00
NOMESCO Finland
Perimetry
4.5
66.2
258
652
WX882
NOMESCO Finland
High dependency care
9.3
65.6
142
166
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
15.6
62.2
104
71
9532/0-C70.0
ICD-O-3
Fibrous meningioma of cerebral meninges
+∞
60.8
58
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.3
58.8
148
220
AA1BD
NOMESCO Finland
Extensive CT of head and brain
7.2
55.2
140
210
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
9.3
52.8
113
129
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
51.3
49
*
N03AF01
ATC
carbamazepine; oral, rectal
4.6
48.8
183
439
ZXC40
NOMESCO Finland
Use of ultrasound
15.6
47.6
79
53
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
61.9
46.6
54
9
AAK00
NOMESCO Finland
Cranioplasty
236.4
45.2
46
*
N75
ICPC
Benign neoplasm nervous system
449.3
44.4
44
*
G40.10
ICD-10 Finland
Simple partial seizures
20.1
42.5
64
33
D32
ICD-10 Finland
Benign neoplasm of meninges
+∞
41.8
40
*
H47.2
ICD-10 Finland
Optic atrophy
40.4
40.8
51
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
40.1
459
2365
WX110
NOMESCO Finland
Local anesthesy
2.0
37.9
1155
8826
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
23.2
37.6
54
24
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
28.6
37.0
50
18
N76
ICPC
Neoplasm nervous system unspecified
84.1
37.0
41
5
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.4
36.0
137
332
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
189.1
35.9
37
*
XA800
NOMESCO Finland
Neuropsychological investigation
5.0
35.6
120
256
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.4
35.6
111
217
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
11.8
34.5
64
56
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
16.1
34.4
56
36
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
94.6
33.8
37
*
R51.80
ICD-10 Finland
Headache
2.5
33.5
307
1396
D33.30
ICD-10 Finland
Acoustic neuroma
20.2
32.7
49
25
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
32.2
338
1646
WX402
NOMESCO Finland
General anaesthesia
2.3
31.8
331
1601
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
11.9
28.7
53
46
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
105.3
28.7
31
*
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
147.5
27.7
29
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
17.0
27.2
43
26
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
63.1
27.0
31
5
WX872
NOMESCO Finland
Intensive care
3.8
26.7
119
333
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
29.8
26.3
35
12
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
24.5
25.7
36
15
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
10.3
24.3
48
48
N03AG01
ATC
valproic acid; systemic, rectal
3.0
23.9
142
495
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
126.8
23.6
25
*
N03AX18
ATC
lacosamide; systemic
19.8
23.5
35
18
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.5
23.3
195
835
N02BE01
ATC
paracetamol; systemic, rectal
2.0
22.8
1450
12829
R4110
NOMESCO Finland
Physiotherapy
1.8
22.8
487
3095
9531/0-C70.9
ICD-O-3
Meningothelial meningioma of meninges, NOS
+∞
21.9
21
*
9537/0-C70.9
ICD-O-3
Transitional meningioma of meninges, NOS
+∞
21.9
21
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
12.9
21.7
38
30
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
10.0
21.1
42
43
CS494
NOMESCO Finland
Other visual field testing
4.6
20.9
73
163
9539/1-C70.9
ICD-O-3
Atypical meningioma of meninges, NOS
+∞
20.9
20
*
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
111.4
20.6
22
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
33.0
20.2
26
8
183
Kela drug reimbursment
Lamotrigin and topiramate
9.3
19.9
41
45
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
11.8
19.8
36
31
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
40.6
19.5
24
6
WF099
NOMESCO Finland
Other radiotherapy
9.7
19.4
39
41
A02BC02
ATC
pantoprazole; systemic
1.6
19.2
1104
9120
H02AB09
ATC
hydrocortisone; systemic
5.1
19.1
61
124
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
18.9
266
1445
WF002
NOMESCO Finland
Radical radiotherapy
3.1
18.5
105
353
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
16.7
17.9
28
17
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.1
17.7
220
1130
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
50.5
17.0
20
*
AAK10
NOMESCO Finland
Repair of dura
50.5
17.0
20
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
4.9
16.7
55
116
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
91.0
16.6
18
*
SPAT1153
SPAT
Removal of sutures
1.6
15.8
545
3886
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
85.9
15.6
17
*
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
85.9
15.6
17
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
15.5
156
730
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
12.5
15.4
27
22
TAB00
NOMESCO Finland
Lumbar puncture
2.8
14.9
95
347
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
57.2
14.8
17
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.4
14.8
125
536
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
7.8
14.6
33
43
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
+∞
14.6
14
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.7
14.5
49
107
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
14.5
191
1006
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
151.3
14.5
15
*
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
151.3
14.5
15
*
S18
ICPC
Laceration/cut
1.5
14.1
679
5210
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.1
13.8
33
47
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
6.1
13.8
37
62
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.8
13.5
33
49
2151
FHL
Resection, big brain
141.1
13.5
14
*
D33.43
ICD-10 Finland
Spinal cord
141.1
13.5
14
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
11.6
13.3
24
21
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
16.9
13.0
20
12
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
10.1
13.0
25
25
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
12.4
12.6
22
18
9533/0-C70.0
ICD-O-3
Psammomatous meningioma of cerebral meninges
+∞
12.5
12
*
2254A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal meninges
+∞
12.5
12
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
130.9
12.4
13
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
12.3
379
2599
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.5
11.9
54
156
101
Kela drug reimbursment
Anterior pituitary hypofunction
9.0
11.8
24
27
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
30.2
11.6
15
5
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
11.6
251
1560
9532/0-C70.9
ICD-O-3
Fibrous meningioma of meninges, NOS
+∞
11.5
11
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
120.8
11.4
12
*
H05.2
ICD-10 Finland
Exophthalmic conditions
17.2
11.2
17
10
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
20.2
11.1
16
8
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.3
11.1
55
171
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.4
11.0
53
161
E23.00
ICD-10 Finland
Panhypopituitarism
10.1
11.0
21
21
N74
ICPC
Malignant neoplasm nervous system
28.2
10.7
14
5
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
60.4
10.6
12
*
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
60.4
10.6
12
*
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
+∞
10.4
10
*
G40.89
ICD-10 Finland
Other epilepsy
9.6
10.3
20
21
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
23.5
10.2
14
6
N18
ICPC
Paralysis/weakness
3.5
10.2
46
134
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
10.1
87
378
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
4.8
10.1
32
67
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.0
10.0
55
185
N29
ICPC
Neurological sympt/complt other
3.4
10.0
46
136
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
40.3
10.0
12
*
N80
ICPC
Head injury other
4.3
9.9
35
82
102
Kela drug reimbursment
Diabetes insipidus
16.8
9.9
15
9
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
16.8
9.9
15
9
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
26.2
9.8
13
5
G40
ICD-10 Finland
Epilepsy
6.2
9.7
25
41
2312
FHL
Extirpation or destruction
55.3
9.7
11
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
9.6
221
1396
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
100.6
9.4
10
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
7.6
9.4
21
28
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
30.2
9.4
12
*
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
30.2
9.4
12
*
9531/0-C70.1
ICD-O-3
Meningothelial meningioma of spinal meninges
+∞
9.4
9
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
8.1
9.3
20
25
N05BA09
ATC
clobazam; oral
9.6
9.3
18
19
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
9.3
150
852
N03AX09
ATC
lamotrigine; oral
2.5
9.2
69
279
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
6.7
9.1
22
33
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
7.8
9.1
20
26
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
4.2
9.1
33
80
AA1AA
NOMESCO Finland
Head X-ray examination
5.3
8.9
26
50
N05CF01
ATC
zopiclone; oral
1.4
8.9
523
4079
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.6
8.9
62
244
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.0
8.8
27
55
WX704
NOMESCO Finland
Intubation
2.0
8.8
119
632
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
50.2
8.7
10
*
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
50.2
8.7
10
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
50.2
8.7
10
*
R42
ICD-10 Finland
Dizziness and giddiness
1.5
8.7
345
2489
K90
ICPC
Stroke/cerebrovascular accident
3.0
8.6
47
159
R20.2
ICD-10 Finland
Paraesthesia of skin
2.0
8.6
106
546
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.8
8.5
54
199
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
90.5
8.4
9
*
9537/0-C70.1
ICD-O-3
Transitional meningioma of spinal meninges
+∞
8.3
8
*
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
+∞
8.3
8
*
AAF00
NOMESCO Finland
Ventriculostomy
5.9
8.3
22
38
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
8.3
170
1038
N88
ICPC
Epilepsy
7.1
8.3
19
27
G91.1
ICD-10 Finland
Obstructive hydrocephalus
8.2
8.1
17
21
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
8.2
8.1
17
21
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
8.0
160
970
NA7FT
NOMESCO Finland
Labeling lesion in spinal area with X-ray guidance
22.1
8.0
11
5
H53.2
ICD-10 Finland
Diplopia
2.6
7.9
56
223
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
7.9
118
651
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
5.1
7.7
23
46
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
7.7
133
771
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
45.2
7.7
9
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
15.1
7.7
12
8
L28
ICPC
Limited function/disability (L)
1.5
7.7
248
1705
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
18.4
7.6
11
6
A28
ICPC
Limited function/disability NOS
1.5
7.6
233
1586
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
7.6
254
1764
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
5.8
7.5
20
35
N28
ICPC
Limited function/disability (N)
3.6
7.4
31
87
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
10.9
7.3
13
12
AAK99
NOMESCO Finland
Other operation on skull or dura
+∞
7.3
7
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
+∞
7.3
7
*
9530/3-C70.0
ICD-O-3
Meningioma, malignant of cerebral meninges
+∞
7.3
7
*
G992, D321
ICD-10 Finland
NA
+∞
7.3
7
*
T32.0
ICD-10 Finland
Corrosions involving less than 10% of body surface
+∞
7.3
7
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
6.3
7.2
18
29
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.9
7.2
97
517
2159
FHL
Other measure in this category
20.1
7.1
10
5
H47.1
ICD-10 Finland
Papilloedema, unspecified
6.6
7.1
17
26
H46
ICD-10 Finland
Optic neuritis
6.1
7.1
18
30
H54.4
ICD-10 Finland
Blindness, monocular
10.1
7.0
13
13
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.1
6.9
25
62
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
8.3
6.8
14
17
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
11.0
6.8
12
11
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
2.2
6.7
67
314
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
16.8
6.7
10
6
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
3.0
6.7
36
122
ZZF00
NOMESCO Finland
Graft of adipose tissue
4.7
6.7
21
45
ZXA05
NOMESCO Finland
Left side
1.4
6.7
405
3149
R4120
NOMESCO Finland
Occupational therapy
1.8
6.6
100
556
ZXC86
NOMESCO Finland
Use of endoscopic device
5.9
6.6
17
29
N06AX11
ATC
mirtazapine; oral
1.3
6.5
472
3778
AA6AD
NOMESCO Finland
Cranial bones CT examination
70.1
6.4
7
*
N19
ICPC
Speech disorder
4.4
6.3
21
48
G41.9
ICD-10 Finland
Status epilepticus, unspecified
6.0
6.3
16
27
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
3.8
6.3
24
63
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
3.8
6.3
24
63
9101
FHL
Bone biopsy
18.1
6.3
9
5
AWE00
NOMESCO Finland
Reoperation for deep heamorrhage in surgery of the nervous system
18.1
6.3
9
5
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
6.3
6
*
9533/0-C70.1
ICD-O-3
Psammomatous meningioma of spinal meninges
+∞
6.3
6
*
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
+∞
6.3
6
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
6.3
6
*
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
+∞
6.3
6
*
AA1CF
NOMESCO Finland
Extensive MRI examination of brain with median intensity magnet
26.8
6.2
8
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
6.2
100
567
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.6
6.2
26
74
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
6.2
233
1655
G82.2
ICD-10 Finland
Paraplegia, unspecified
5.8
6.1
16
28
H93.1
ICD-10 Finland
Tinnitus
1.8
6.1
100
573
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.9
6.0
18
37
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
322
93
41.85
307.65
1.6
2.1
—
—
—
0
0
616
1786
4.70
197.61
4.9
7.4
1.2
1.2
mmol/l
0.06
423
1412
613
1793
4.65
194.02
4.9
7.3
4.9
5.1
kpa
5.66
593
1715
613
1794
4.64
193.86
4.9
7.3
17.6
12.2
kpa
52.50
593
1717
393
823
5.81
184.44
3.8
8.9
24.1
24.5
mmol/l
1.99
387
771
79
61
13.49
83.15
2.3
2.3
54.7
52.3
umol/l
0.20
65
43
113
148
8.07
81.76
2.0
1.5
—
—
—
0
0
1145
7425
2.46
72.91
5.7
5.7
1.2
1.2
mmol/l
19.05
1071
6678
1208
8129
2.44
69.16
6.6
6.5
1.2
1.2
mmol/l
11.83
1074
6835
1294
9072
2.47
66.11
5.5
4.6
6.6
6.7
mmol/l
1.79
1257
8508
74
74
10.38
65.82
2.2
1.8
—
—
—
0
0
668
3822
2.18
52.00
2.3
2.3
—
—
—
0
0
469
2353
2.34
49.96
1.9
2.0
28.2
29.6
s
7.45
451
2276
1044
7218
2.05
47.55
3.7
4.0
—
—
—
0
0
334
1476
2.55
46.82
6.9
8.2
121.0
119.4
g/l
0.90
329
1424
130
333
4.13
45.64
1.9
1.4
2130.5
949.2
e6/l
0.86
112
271
130
333
4.13
45.64
1.8
1.3
111.9
25.6
e6/l
1.15
110
256
253
987
2.82
45.38
6.1
8.4
95.7
94.0
%
11.36
253
981
252
983
2.81
45.20
6.1
8.4
0.8
0.7
%
6.00
252
977
252
992
2.79
44.39
6.0
8.2
1.4
1.3
%
0.39
252
985
346
1593
2.45
44.21
6.8
7.8
97.7
95.6
%
17.63
341
1537
225
973
2.50
32.35
9.2
7.4
25.2
24.6
mmol/l
2.71
219
910
155
558
2.94
31.91
4.6
3.6
1.2
1.4
mmol/l
1.38
155
548
727
4881
1.81
31.73
2.3
2.1
152.7
208.0
u/l
1.76
699
4562
120
376
3.35
31.25
1.4
1.2
765.1
532.7
mg/l
2.24
115
357
111
344
3.37
29.40
1.4
1.2
3.5
3.8
mmol/l
1.93
100
323
54
97
5.71
28.89
2.3
1.9
15.9
17.6
nmol/l
0.82
54
89
279
1459
2.08
25.16
3.0
2.1
364.3
373.8
nmol/l
0.33
262
1322
39
62
6.41
23.58
3.3
3.0
27.9
29.7
umol/l
0.33
34
44
253
1320
2.06
22.84
4.4
6.7
6.9
9.8
mmol/l
12.45
237
1255
97
336
2.99
21.33
2.7
1.6
417.8
307.8
mu/l
1.87
92
298
69
219
3.24
17.62
3.4
5.0
342.5
367.6
umol/l
0.87
64
187
17
16
10.72
15.55
2.0
1.3
—
—
—
0
0
64
235
2.79
12.74
1.5
1.2
12.8
14.2
u/l
0.28
52
180
304
2041
1.59
11.30
6.4
7.3
—
—
—
0
0
562
4336
1.43
10.52
3.0
3.1
0.3
0.5
e6/l
2.62
451
3269
146
819
1.85
10.48
9.0
10.6
—
—
—
0
0
107
546
2.02
10.16
1.6
1.3
30.6
34.8
iu/l
0.61
97
465
104
533
2.01
9.77
1.8
2.3
282.4
830.5
ug/l
0.80
92
500
357
2565
1.49
9.60
2.3
3.2
0.8
0.8
mmol/l
4.70
337
2368
1609
15099
1.56
8.49
17.9
14.9
22.7
23.3
mg/l
0.28
1446
12012
1331
12120
1.36
7.76
4.5
4.3
14.8
14.9
pmol/l
0.26
1213
10951
286
2056
1.46
7.55
4.3
5.0
1.0
1.0
mmol/l
0.93
260
1876
14
25
5.64
7.54
2.8
2.6
44.6
40.2
umol/l
0.24
14
17
19
46
4.16
7.28
1.0
1.1
—
—
—
0
0
1661
15800
1.58
7.12
21.6
17.3
139.5
139.7
mmol/l
1.58
1636
15382
1663
15835
1.58
6.95
21.4
17.4
3.9
4.0
mmol/l
1.69
1634
15396
717
6045
1.31
6.91
3.6
3.7
28.5
53.2
ng/l
1.27
523
4259
1155
10390
1.31
6.75
5.3
4.9
199.3
2415.5
e6/l
2.45
15
152
105
615
1.75
6.60
7.8
6.4
1.5
1.6
%
0.30
96
578
22
65
3.41
6.42
1.4
1.2
20.0
72.6
%
—
6
9
942
8306
1.28
6.17
5.8
6.1
10.1
11.0
umol/l
1.23
887
7875
25
86
2.93
5.74
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
82
2.95
5.58
1.0
1.2
—
—
—
0
0
16
43
3.75
5.37
1.1
1.2
19.9
12.1
%
—
8
7
341
2670
1.34
5.36
2.7
2.7
1.0
1.4
e6/l
1.54
212
1496
1510
14253
1.35
5.36
5.4
5.2
1.8
2.2
mu/l
1.43
1383
12937
387
3098
1.32
5.20
1.7
1.8
1114.4
1197.4
nmol/l
1.03
292
2284
411
3319
1.31
5.19
2.5
2.6
5.6
6.5
e6/l
0.80
371
2916
1261
11643
1.27
5.14
4.2
4.3
12.7
13.3
mm/h
0.60
1178
10718
8
6
13.38
5.08
1.4
1.7
—
—
—
0
0
93
574
1.65
4.90
2.0
2.1
10.7
12.1
nmol/l
0.83
73
500
315
2472
1.33
4.85
2.8
2.9
4.4
3.1
e6/l
0.91
186
1311
135
927
1.49
4.50
1.4
1.5
—
—
—
0
0
187
1386
1.39
4.15
2.0
2.5
5.4
6.6
ug/l
0.73
163
1200
32
148
2.18
4.09
3.0
2.2
—
—
—
0
0
146
1041
1.44
4.04
2.2
2.4
20.0
25.1
au/ml
—
7
48
1509
14381
1.29
3.98
15.7
14.1
80.3
77.4
ml/min/173m2
6.41
1345
11896
991
9045
1.21
3.91
8.6
9.0
4.2
4.0
e9/l
1.19
864
7878
8
13
6.18
3.50
1.3
1.4
26.3
44.4
%
—
8
7
316
2591
1.27
3.45
1.8
1.8
—
—
—
0
0
70
445
1.60
3.37
1.9
1.7
—
—
—
0
0
784
7065
1.19
3.37
4.4
4.6
35.0
35.3
g/l
0.83
718
6559
164
1245
1.35
3.18
2.9
2.6
60.6
63.3
ml/min/173m2
0.37
55
524
367
3098
1.23
3.09
3.9
3.8
193.9
304.3
ng/l
0.51
281
2459
7
12
5.85
3.02
1.3
1.4
14.6
19.0
%
—
7
7
32
168
1.92
3.00
1.3
1.4
0.2
0.3
nmol/l
0.70
23
125
214
1706
1.29
2.94
2.4
2.6
8.6
7.7
umol/l
0.15
184
1487
187
1465
1.31
2.93
2.5
2.2
32.2
38.4
u/l
1.38
162
1245
84
576
1.48
2.92
1.8
1.8
—
—
—
0
0
209
1668
1.29
2.85
3.4
3.4
—
—
—
0
0
131
985
1.36
2.73
3.2
3.2
4.3
4.4
pmol/l
0.81
120
852
744
6768
1.17
2.68
2.0
2.0
96.4
96.1
pmol/l
0.05
361
3277
150
1157
1.32
2.65
1.5
1.6
—
—
—
0
0
9
26
3.47
2.48
1.4
1.2
90.3
82.1
ng/l
—
9
26
546
4871
1.17
2.48
3.1
3.1
31.8
34.0
u/l
0.34
512
4620
1278
12158
1.17
2.47
7.8
7.6
76.8
78.5
u/l
0.87
1203
11392
88
632
1.41
2.44
1.9
1.9
—
—
—
0
0
53
345
1.55
2.39
1.4
1.3
—
—
—
0
0
53
345
1.55
2.39
1.4
1.3
—
—
—
0
0
26
139
1.88
2.37
1.0
1.1
—
—
—
0
0
8
23
3.49
2.27
1.1
1.2
—
—
—
0
0
747
6869
1.15
2.21
2.3
2.3
77.3
79.5
nmol/l
1.30
655
6089
813
7534
1.14
2.13
4.0
4.0
0.0
0.0
estimate
0.00
158
1383
817
7585
1.14
2.06
5.5
5.4
0.0
0.0
estimate
0.50
161
1387
1010
9510
1.14
2.05
3.3
3.1
45.5
48.3
u/l
0.66
940
8750
825
7670
1.14
2.03
4.1
4.0
0.0
0.0
estimate
1.08
158
1371
636
5815
1.14
2.00
3.3
3.5
2.4
2.4
mmol/l
0.79
540
5051
18
90
2.01
2.00
1.1
1.1
0.9
1.2
u/l
2.12
11
51
14
64
2.20
1.94
1.1
1.1
—
14.6
u/ml
—
0
9
6
16
3.76
1.93
1.2
1.1
—
—
—
0
0
6
16
3.76
1.93
1.2
1.1
—
—
—
0
0
33
203
1.64
1.93
1.2
1.2
3.3
5.6
u/ml
—
10
79
217
1829
1.21
1.88
1.6
1.7
—
—
—
0
0
7
23
3.05
1.80
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
69
505
1.38
1.79
2.9
2.7
0.3
0.4
u/ml
1.14
39
291
390
3474
1.16
1.76
1.8
1.7
450.4
19893868.6
pmol/l
2.15
324
2815
31
193
1.62
1.75
1.1
1.1
—
—
—
0
0
48
332
1.46
1.71
1.6
1.5
—
—
—
0
0
244
2102
1.19
1.68
17.7
25.3
1.4
1.3
inr
0.16
27
274
166
1382
1.22
1.65
3.3
3.4
86.0
85.1
ng/l
0.06
138
1175
5
14
3.58
1.61
1.2
2.1
—
—
—
0
0
240
2077
1.18
1.58
4.8
4.7
32.6
33.2
%
0.47
165
1353
449
4071
1.14
1.57
4.4
4.4
0.0
0.0
estimate
0.88
158
1360
162
1360
1.21
1.50
2.3
2.8
65.3
66.4
g/l
1.04
146
1223
69
523
1.33
1.48
3.9
3.5
35.3
66.6
mg/l
1.45
58
435
384
3462
1.14
1.46
1.7
1.7
1.6
1.2
mg/l
0.39
300
2676
64
482
1.34
1.44
1.2
1.2
—
—
—
0
0
5
16
3.13
1.44
1.0
1.3
—
—
—
0
0
25
156
1.61
1.44
3.3
3.1
71.5
55.9
%
2.97
17
100
23
141
1.64
1.42
1.2
1.1
87.0
95.4
%
0.75
23
134
212
1834
1.18
1.41
1.7
1.8
—
—
—
0
0
31
206
1.51
1.38
1.3
1.8
89.7
89.8
%
0.02
31
206
77
600
1.30
1.38
1.2
1.2
0.2
1.1
u/ml
—
10
47
694
6505
1.11
1.34
2.8
2.7
135.6
119.3
ug/l
0.68
624
5964
13
68
1.92
1.33
1.5
1.3
—
—
—
0
0
68
524
1.31
1.33
4.0
3.5
34.9
51.9
mg/l
0.69
57
436
37
258
1.44
1.32
3.7
3.3
1.8
1.4
%
0.12
28
199
361
3267
1.13
1.30
3.1
3.1
2.5
2.5
mmol/l
0.53
301
2888
29
193
1.51
1.29
1.8
1.8
47.7
42.4
nmol/l
0.56
29
183
16
91
1.76
1.29
1.9
1.6
—
—
—
0
0
32
218
1.48
1.28
1.3
1.8
8041.1
1432.6
u/l
0.53
11
81
60
458
1.32
1.26
1.5
1.6
1.2
1.2
g/l
0.04
54
432
39
278
1.41
1.25
1.4
1.5
—
—
—
0
0
116
966
1.21
1.20
1.8
1.6
—
—
—
0
0
422
3875
1.12
1.19
1.5
1.6
20.3
21.3
nmol/l
0.71
366
3257
48
358
1.35
1.19
1.4
1.5
—
—
—
0
0
43
316
1.37
1.17
2.0
2.8
25.8
36.1
umol/l
4.43
37
267
77
616
1.26
1.16
2.1
2.0
3.3
1.8
ug/l
0.38
59
538
81
652
1.25
1.16
1.6
1.9
33.3
39.6
u/l
2.95
70
572
249
2782
0.88
1.13
1.3
1.4
—
—
—
0
0
25
168
1.49
1.10
1.5
1.5
—
—
—
0
0
83
676
1.24
1.08
5.0
3.5
49.1
48.4
%
0.08
83
668
111
932
1.20
1.08
3.5
3.5
5.2
5.2
kpa
0.04
97
865
1632
16070
1.15
1.05
11.8
11.0
24.9
24.5
u/l
0.32
1585
15466
7
33
2.13
1.05
1.4
1.3
—
—
—
0
0
7
33
2.13
1.05
2.1
2.6
—
—
—
0
0
12
67
1.80
1.04
2.3
2.6
1290.8
1173.4
u/ml
0.07
12
67
9
46
1.96
1.03
1.0
1.1
1626.4
1728.4
miu/ml
—
9
46
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
16
98
1.64
1.03
1.4
1.4
0.9
1.1
promille
—
10
74
16
98
1.64
1.03
1.1
1.1
—
—
—
0
0
13
75
1.74
1.02
1.0
1.0
—
—
—
0
0
48
368
1.31
1.02
1.4
1.5
—
—
—
0
0
13
76
1.72
0.99
2.3
2.6
—
—
—
0
0
23
156
1.48
0.98
1.5
1.6
—
—
—
0
0
5
23
2.18
0.98
1.0
1.3
—
—
—
0
0
9
51
1.77
0.94
1.3
1.6
15.8
15.0
pmol/l
—
9
39
1267
12335
1.09
0.94
21.6
18.3
13.8
13.8
%
0.12
1239
12046
27
374
0.72
0.94
2.2
2.4
107.3
89.9
ug/min
0.11
13
220
159
1804
0.87
0.93
3.5
4.1
27.3
21.3
ug/l
0.10
129
1485
247
2237
1.12
0.91
2.3
2.4
2.3
2.3
g/l
0.72
223
2071
8
42
1.91
0.88
1.0
1.1
—
—
—
0
0
1676
16562
1.15
0.88
27.0
22.2
257.8
254.3
e9/l
1.41
1649
16117
18
119
1.52
0.88
1.1
1.0
—
—
—
0
0
155
1367
1.15
0.87
3.7
3.5
1.2
1.2
mmol/l
0.66
139
1189
8
43
1.86
0.87
1.0
1.1
—
—
—
0
0
431
4027
1.09
0.87
2.3
2.2
3.0
3.1
mg/l
0.47
365
3400
29
391
0.74
0.87
1.6
1.8
—
—
—
0
0
35
264
1.33
0.86
3.8
5.2
140.0
317.8
iu/ml
—
5
36
1676
16568
1.15
0.84
27.0
22.2
7.0
6.6
e9/l
8.72
1644
16062
1676
16568
1.15
0.84
27.0
22.2
4.4
4.4
e12/l
0.12
1643
16064
6
31
1.94
0.84
1.0
1.3
—
—
—
0
0
8
45
1.78
0.84
1.0
1.2
—
—
—
0
0
1519
14938
1.10
0.82
5.0
4.8
5.9
6.0
mmol/l
3.14
1373
13454
8
46
1.74
0.82
1.0
1.2
—
—
—
0
0
468
4971
0.92
0.82
3.7
3.9
8.3
8.3
mg/mmol
0.00
282
2971
1676
16573
1.14
0.81
27.1
22.3
131.7
132.8
g/l
2.85
1661
16306
120
1046
1.16
0.81
2.4
3.7
25.6
63.0
u/ml
3.19
115
1013
230
2092
1.11
0.80
2.4
2.4
21.4
21.9
%
0.17
205
1787
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
69
575
1.21
0.78
4.2
3.8
25.3
25.0
mmol/l
0.33
61
532
41
322
1.28
0.78
1.8
2.4
15.0
15.9
%
0.37
14
157
156
1390
1.13
0.77
3.1
3.3
1.6
2.0
mmol/l
0.89
126
1136
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
129
1137
1.14
0.76
2.8
2.8
9.6
10.5
g/l
1.78
119
1026
265
2438
1.10
0.75
2.4
2.4
13.0
12.6
umol/l
0.29
247
2252
1447
14215
1.09
0.75
5.9
6.0
39.4
40.0
mmol/mol
2.35
1331
13044
78
661
1.19
0.75
2.2
2.5
3.5
3.7
g/l
0.99
53
478
78
662
1.19
0.74
2.2
2.5
—
—
—
0
0
16
108
1.49
0.73
1.1
1.1
—
—
—
0
0
5
25
2.00
0.72
1.0
1.2
—
—
—
0
0
7
39
1.80
0.72
1.3
1.2
—
—
—
0
0
9
56
1.61
0.72
1.0
1.0
—
—
—
0
0
462
4883
0.93
0.71
2.9
3.1
6.7
6.8
mmol/l
0.18
391
4065
176
1590
1.12
0.71
3.1
3.2
0.8
0.8
ug/l
0.25
122
1094
19
134
1.42
0.71
1.0
1.3
—
—
—
0
0
7
40
1.75
0.71
1.0
1.2
—
—
—
0
0
31
238
1.31
0.71
1.3
1.2
—
—
—
0
0
5
26
1.93
0.70
1.2
1.2
—
—
—
0
0
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
193
1754
1.11
0.70
4.3
4.0
242.1
247.7
u/l
0.17
180
1647
20
143
1.40
0.70
1.1
1.1
—
—
—
0
0
9
58
1.55
0.69
1.1
1.2
—
—
—
0
0
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
7
42
1.67
0.68
1.3
1.9
—
—
—
0
0
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
101
883
1.15
0.68
3.6
3.5
2.4
1.9
mmol/l
0.54
66
671
7
119
0.59
0.67
1.0
1.3
—
—
—
0
0
7
119
0.59
0.67
1.0
1.3
—
—
—
0
0
7
120
0.58
0.67
1.0
1.3
—
—
—
0
0
7
120
0.58
0.67
1.0
1.3
—
—
—
0
0
29
223
1.31
0.66
1.3
1.5
—
—
—
0
0
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
879
8512
1.06
0.65
2.6
2.7
—
—
—
0
0
77
662
1.17
0.65
2.2
2.5
7.2
7.5
g/l
0.63
56
501
81
700
1.16
0.64
1.9
1.8
1.6
1.5
g/l
0.25
72
608
14
95
1.48
0.64
1.6
2.0
1198.1
733.5
e6/l
—
7
42
5
30
1.67
0.61
1.2
1.7
1.3
1.2
mmol/l
—
5
30
15
207
0.72
0.57
1.4
1.9
16759.2
22.9
u/ml
0.48
15
202
6
36
1.67
0.56
1.2
1.2
—
—
—
0
0
63
731
0.86
0.56
1.8
1.8
—
—
—
0
0
72
625
1.16
0.56
2.3
2.6
3.2
3.1
g/l
0.22
53
489
15
107
1.41
0.55
1.4
1.4
—
—
—
0
0
14
194
0.72
0.55
1.5
1.5
—
—
—
0
0
54
459
1.18
0.54
1.2
1.2
27.7
39.5
u/ml
—
5
32
8
123
0.65
0.54
1.0
1.5
—
—
—
0
0
23
177
1.30
0.54
1.3
1.6
—
—
—
0
0
14
193
0.72
0.53
1.1
1.0
1.6
3.1
u/ml
—
6
76
15
108
1.39
0.53
1.1
1.2
—
—
—
0
0
599
5774
1.06
0.51
4.5
4.2
—
—
—
0
0
142
1549
0.91
0.49
2.0
2.1
0.2
0.2
g/l
1.44
129
1450
86
766
1.13
0.49
3.2
2.7
0.7
0.4
e6/l
0.39
86
744
42
354
1.19
0.48
1.3
1.2
—
—
—
0
0
7
111
0.63
0.48
1.1
1.5
8.6
13.2
umol/l
—
7
105
70
616
1.14
0.48
2.3
2.5
9.3
10.0
g/l
0.88
58
522
192
1787
1.08
0.47
2.6
2.5
1.8
1.8
%
0.18
174
1576
57
495
1.16
0.46
1.5
1.9
—
—
—
0
0
7
49
1.43
0.46
1.0
1.2
120.3
112.7
%
—
7
40
294
2784
1.07
0.45
1.3
1.3
43.8
38.3
iu/ml
0.20
95
892
14
103
1.36
0.45
1.6
1.5
0.9
1.0
g/l
0.33
14
103
7
50
1.40
0.45
1.1
1.1
777.8
193.3
iu/ml
—
7
50
32
265
1.21
0.44
1.2
1.4
—
—
—
0
0
83
925
0.89
0.44
1.2
1.2
216.2
161.7
u/ml
0.21
78
847
28
229
1.23
0.44
1.2
1.4
—
—
—
0
0
47
405
1.16
0.43
1.7
1.8
2.7
4.7
iu/l
2.51
13
134
5
31
1.61
0.43
1.0
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
2.1
—
1.1
—
0
10
150
1392
1.08
0.41
2.3
2.9
158.4
200.9
ng/l
1.00
138
1274
26
213
1.22
0.41
1.9
2.3
19.1
28.4
mg/l
—
7
56
25
205
1.22
0.39
1.2
1.4
—
—
—
0
0
74
822
0.90
0.39
1.8
1.8
—
—
—
0
0
17
133
1.28
0.38
1.6
1.4
—
—
—
0
0
17
133
1.28
0.38
1.6
1.4
—
—
—
0
0
17
133
1.28
0.38
1.6
1.4
—
—
—
0
0
54
610
0.88
0.38
2.9
3.5
6585.8
2508.9
u/ml
0.37
44
533
9
68
1.33
0.37
1.0
1.2
—
—
—
0
0
25
300
0.83
0.37
2.2
1.6
0.7
0.8
nmol/l
0.47
20
242
25
300
0.83
0.37
4.2
3.0
4.3
4.2
e9/l
0.09
25
300
26
310
0.84
0.36
5.0
3.3
59.9
57.8
%
0.45
26
310
64
574
1.12
0.36
2.4
2.7
0.8
1.0
g/l
0.17
56
499
39
338
1.16
0.35
2.7
3.8
33.9
24.6
mg/l
0.40
16
211
1546
15330
1.06
0.35
5.1
5.2
2.8
2.8
mmol/l
2.39
1414
13952
68
753
0.90
0.35
1.0
1.0
—
—
—
0
0
17
135
1.26
0.35
1.7
1.5
16.1
33.1
%
1.86
12
84
1513
14996
1.05
0.35
4.6
4.6
4.8
4.7
mmol/l
1.67
1389
13718
6
46
1.31
0.33
1.5
1.2
—
—
—
0
0
59
530
1.12
0.33
2.5
2.5
36.4
37.6
g/l
0.76
51
451
25
210
1.19
0.32
1.3
1.4
99.0
114.5
u/ml
—
6
43
25
210
1.19
0.32
1.2
1.4
—
—
—
0
0
499
4843
1.04
0.32
2.6
3.0
1289.9
1300.3
ng/l
0.02
429
4130
57
512
1.12
0.32
1.5
1.4
283.1
288.3
ug/g
0.06
32
290
25
211
1.19
0.31
1.4
1.3
—
—
—
0
0
1357
13430
1.04
0.31
19.5
16.3
38.5
38.9
%
0.69
956
9103
96
1036
0.92
0.31
1.3
1.2
201.3
142.3
iu/ml
0.59
36
385
20
166
1.21
0.30
2.8
3.6
—
—
—
0
0
15
185
0.81
0.29
1.0
1.1
—
—
—
0
0
18
148
1.22
0.29
1.1
1.3
—
—
—
0
0
10
77
1.30
0.26
1.0
1.1
—
—
—
0
0
5
73
0.68
0.26
1.2
1.2
105.6
394.2
u/l
—
5
66
37
329
1.13
0.26
1.4
1.4
—
—
—
0
0
34
379
0.90
0.22
3.1
3.2
0.8
0.8
nmol/l
0.01
26
295
7
93
0.75
0.22
1.0
1.3
—
—
—
0
0
7
95
0.74
0.22
1.9
1.9
—
—
—
0
0
50
458
1.09
0.22
1.2
1.2
—
—
—
0
0
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
440
4297
1.03
0.22
1.6
1.7
1.4
1.4
mmol/l
0.14
375
3595
11
135
0.81
0.22
1.0
1.4
1.0
1.4
nmol/l
1.11
11
117
34
378
0.90
0.22
3.1
3.9
35.3
34.1
u/ml
0.02
34
369
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
41
449
0.91
0.20
1.5
1.7
—
—
—
0
0
25
221
1.13
0.20
1.2
1.2
230.9
289.2
u/ml
0.69
18
120
16
136
1.18
0.20
1.8
2.3
1.6
2.3
u/field
—
7
55
13
108
1.21
0.20
1.2
1.2
—
—
—
0
0
11
90
1.22
0.19
1.5
1.5
—
—
—
0
0
11
90
1.22
0.19
1.5
1.5
—
—
—
0
0
503
4934
1.03
0.19
2.6
2.5
69.5
57.9
u/l
0.60
462
4532
407
3982
1.03
0.18
2.6
2.6
4574.6
6109.9
umol/l
0.33
352
3383
22
194
1.14
0.18
2.3
1.6
69.3
58.9
%
0.85
14
126
14
164
0.85
0.18
1.6
1.6
—
—
—
0
0
15
128
1.17
0.18
1.4
1.6
—
—
—
0
0
7
58
1.21
0.18
2.4
1.9
11.8
158.6
ug/l
—
7
50
172
1783
0.96
0.18
1.7
2.0
101.1
133.1
ug/g
0.82
126
1392
1496
14880
1.03
0.18
4.6
4.6
1.5
1.5
mmol/l
0.38
1361
13519
41
377
1.09
0.18
2.2
3.0
24.8
25.4
mmol/l
0.42
34
328
39
358
1.09
0.17
1.2
1.3
—
—
—
0
0
11
91
1.21
0.17
1.7
1.2
—
—
—
0
0
24
214
1.12
0.17
1.3
1.3
—
—
—
0
0
12
142
0.84
0.17
1.3
1.3
7.3
6.6
mmol/l
0.28
12
133
44
474
0.93
0.16
1.1
1.2
—
—
—
0
0
77
730
1.06
0.16
2.0
2.4
1.2
1.2
%
0.15
77
725
11
92
1.20
0.16
1.7
1.2
—
—
—
0
0
15
172
0.87
0.15
1.2
1.2
40.8
53.9
u/l
—
8
125
6
78
0.77
0.15
1.0
1.4
—
—
—
0
0
6
78
0.77
0.15
1.0
1.4
—
—
—
0
0
36
332
1.09
0.15
1.2
1.3
221.1
241.1
miu/ml
0.12
15
149
41
381
1.08
0.15
1.3
1.5
—
—
—
0
0
47
502
0.93
0.14
1.6
1.7
3.9
4.2
mg/l
0.09
35
361
24
217
1.11
0.14
1.3
1.3
—
—
—
0
0
17
150
1.13
0.14
4.8
4.5
11.4
46.0
u/ml
—
5
43
74
705
1.05
0.13
2.4
3.3
24.0
24.2
mmol/l
0.23
69
640
1445
14383
1.02
0.13
4.1
4.1
1.3
1.3
mmol/l
0.22
1303
12957
24
218
1.10
0.13
1.3
1.3
—
—
—
0
0
48
451
1.07
0.13
1.5
1.5
0.1
0.1
iu/ml
0.33
13
91
44
469
0.94
0.13
1.1
1.2
—
—
—
0
0
11
127
0.87
0.12
1.6
1.6
—
—
—
0
0
47
498
0.94
0.12
2.0
2.9
—
—
—
0
0
45
424
1.06
0.12
1.6
1.4
—
—
—
0
0
108
1045
1.04
0.11
1.8
1.7
—
—
—
0
0
48
506
0.95
0.11
1.4
1.5
—
—
—
0
0
224
2194
1.02
0.11
4.8
4.5
21.2
21.1
%
0.05
128
1102
5
47
1.06
0.09
1.2
1.2
—
—
—
0
0
138
1414
0.97
0.09
1.8
1.7
1.5
1.5
%
0.47
119
1212
12
134
0.89
0.08
1.4
1.8
3.5
4.0
mg/l
0.30
12
129
22
204
1.08
0.08
1.2
1.1
0.8
1.1
u/ml
—
5
76
23
214
1.08
0.08
1.3
1.3
—
—
—
0
0
23
214
1.08
0.08
1.3
1.3
—
—
—
0
0
71
734
0.97
0.08
1.2
1.4
—
—
—
0
0
7
66
1.06
0.08
2.0
1.5
—
—
—
0
0
7
66
1.06
0.08
2.0
1.5
—
—
—
0
0
7
67
1.04
0.08
2.0
1.5
—
—
—
0
0
12
133
0.90
0.07
2.7
2.1
—
—
—
0
0
218
2214
0.98
0.07
1.4
1.4
—
—
—
0
0
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
8
77
1.04
0.07
1.1
1.4
—
—
—
0
0
12
108
1.11
0.07
1.0
1.0
859.6
698.3
ng/l
—
7
70
8
78
1.03
0.07
5.6
3.3
—
—
—
0
0
7
84
0.83
0.07
1.6
1.4
—
—
—
0
0
39
373
1.05
0.07
1.2
1.1
—
—
—
0
0
23
216
1.07
0.06
1.3
1.3
—
—
—
0
0
8
95
0.84
0.06
1.0
1.3
—
—
—
0
0
18
193
0.93
0.06
2.4
2.0
31.8
32.1
pg
0.10
18
193
19
203
0.94
0.06
1.2
1.1
—
—
—
0
0
56
577
0.97
0.05
1.4
1.4
—
—
—
0
0
272
2696
1.01
0.04
1.3
1.3
7.4
12.3
u/ml
0.79
104
1012
335
3325
1.01
0.04
4.6
4.5
1.0
1.0
kg/l
0.82
55
487
276
2738
1.01
0.04
5.9
5.3
3.0
2.9
ug/l
0.06
243
2407
37
382
0.97
0.04
2.0
1.7
9646.3
12824.7
e6/l
0.38
28
281
21
200
1.05
0.03
1.0
1.6
—
—
—
0
0
22
210
1.05
0.03
1.1
1.1
—
—
—
0
0
37
380
0.97
0.03
1.5
1.3
—
—
—
0
0
12
128
0.94
0.02
1.1
1.3
456.0
320.9
u/l
0.27
12
122
13
138
0.94
0.02
1.2
1.5
—
—
—
0
0
33
321
1.03
0.02
2.4
1.6
—
—
—
0
0
22
212
1.04
0.02
1.2
1.1
—
—
—
0
0
27
276
0.98
0.00
1.4
1.3
—
—
—
0
0
332
3327
1.00
0.00
1.2
1.2
0.8
1.4
u/ml
2.07
74
848
44
434
1.01
0.00
1.3
1.2
24.4
10.3
u/ml
—
10
84
12
115
1.04
0.00
1.3
1.1
—
—
—
0
0
16
165
0.97
0.00
1.6
1.3
6456.3
100761.7
e6/l
—
10
89
34
335
1.02
0.00
1.8
2.1
125.9
127.3
g/l
0.12
17
241
11
112
0.98
0.00
1.0
1.2
—
—
—
0
0
11
112
0.98
0.00
1.0
1.2
—
—
—
0
0
11
113
0.97
0.00
1.0
1.2
—
—
—
0
0
11
113
0.97
0.00
1.0
1.2
—
—
—
0
0
11
113
0.97
0.00
1.0
1.2
—
—
—
0
0
13
133
0.98
0.00
1.9
2.3
713.8
624.7
ml
—
8
92
41
413
0.99
0.00
2.3
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
2.6
—
0
8
0
8
0.00
0.00
0.0
1.1
—
7.7
—
0
8
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
8
80
1.00
0.00
1.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
4.0
—
—
—
0
0
6
69
0.87
0.00
1.7
1.2
—
—
—
0
0
6
69
0.87
0.00
1.7
1.2
—
—
—
0
0
6
68
0.88
0.00
12.8
10.6
0.7
0.6
mmol/l
—
6
63
8
79
1.01
0.00
1.4
1.3
—
—
—
0
0
8
79
1.01
0.00
2.0
1.5
—
—
—
0
0
8
79
1.01
0.00
2.0
1.5
—
—
—
0
0
8
79
1.01
0.00
2.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
7
69
1.01
0.00
1.0
1.1
—
—
—
0
0
8
79
1.01
0.00
2.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
0.00
1.7
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MENINGIOMA – Brain meningioma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).